E
Eva Untersmayr
Researcher at Medical University of Vienna
Publications - 119
Citations - 3892
Eva Untersmayr is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Food allergy & Allergy. The author has an hindex of 32, co-authored 104 publications receiving 3064 citations.
Papers
More filters
Journal ArticleDOI
The role of protein digestibility and antacids on food allergy outcomes.
TL;DR: Antiulcer agents impeding gastric protein digestion have a major effect on the sensitization and effector phase of food allergy.
Journal ArticleDOI
Antacid medication inhibits digestion of dietary proteins and causes food allergy: A fish allergy model in Balb/c mice
Eva Untersmayr,Isabella Schöll,Ines Swoboda,Waltraud J. Beil,Elisabeth Förster-Waldl,Franziska Walter,Angelika B. Riemer,Georg Kraml,Tamar Kinaciyan,Susanne Spitzauer,George Boltz-Nitulescu,Otto Scheiner,Erika Jensen-Jarolim +12 more
TL;DR: When antacid medication impairs the gastric digestion, IgE synthesis toward novel dietary proteins is promoted, leading to food allergy.
Journal ArticleDOI
Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients
Eva Untersmayr,Noemi Bakos,Isabella Schöll,Michael Kundi,Franziska Roth-Walter,Krisztina Szalai,Angelika B. Riemer,Hendrik Jan Ankersmit,Otto Scheiner,George Boltz-Nitulescu,Erika Jensen-Jarolim +10 more
TL;DR: The data strongly suggest that anti‐ulcer treatment primes the development of IgE toward dietary compounds in long‐term acid‐suppressed patients.
Journal ArticleDOI
Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans
Isabella Schöll,Eva Untersmayr,Noemi Bakos,Franziska Roth-Walter,Andreas Gleiss,George Boltz-Nitulescu,Otto Scheiner,Erika Jensen-Jarolim +7 more
TL;DR: The experimental and epidemiologic data suggest that the intake of antiulcer drugs may lead to the induction of immediate-type food hypersensitivity toward hazelnut.
Journal ArticleDOI
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).
Milena Sokolowska,Zuzanna Lukasik,Zuzanna Lukasik,Ioana Agache,Cezmi A. Akdis,Deniz Akdis,Mübeccel Akdis,Weronika Barcik,Helen A. Brough,Thomas Eiwegger,Andrzej Eljaszewicz,Stefanie Eyerich,Wojciech Feleszko,Cristina Gomez-Casado,Karin Hoffmann-Sommergruber,Jozef Janda,Rodrigo Jiménez-Saiz,Rodrigo Jiménez-Saiz,Marek Jutel,Edward F. Knol,Inge Kortekaas Krohn,Akash Kothari,Joanna Makowska,Marcin Moniuszko,Hideaki Morita,Liam O'Mahony,Kari C. Nadeau,Cevdet Ozdemir,Isabella Pali-Schöll,Isabella Pali-Schöll,Oscar Palomares,Francesco Papaleo,Mary Prunicki,Carsten B. Schmidt-Weber,Anna Sediva,Jürgen Schwarze,Mohamed H. Shamji,Gerdien A. Tramper-Stranders,Willem van de Veen,Eva Untersmayr +39 more
TL;DR: The differences between adequate innate and adaptive immune response in mild disease and the deep immune dysfunction in the severe multiorgan disease are characterized and the knowledge gaps and urgent research requirements are highlighted to provide a quick roadmap for ongoing and needed COVID‐19 studies.